Bioasis Provides Corporate Update and Announces Suspension of Operations
20. Juni 2023 17:25 ET
|
Bioasis Technologies Inc.
NEW HAVEN, Conn., June 20, 2023 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the “Company” or “Bioasis”), a multi-asset rare and orphan disease biopharmaceutical company...
Bioasis Provides Update on Business Operations
23. März 2023 17:05 ET
|
Bioasis Technologies Inc.
NEW HAVEN, Conn., March 23, 2023 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the “Company” or “Bioasis”), a multi-asset rare and orphan disease biopharmaceutical company...
Bioasis Announces AGM Results and Provides Update on Financial Position
03. Februar 2023 17:39 ET
|
Bioasis Technologies Inc.
NEW HAVEN, Conn., Feb. 03, 2023 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the “Company” or “Bioasis”), a multi-asset rare and orphan disease biopharmaceutical company...
Bioasis Technologies Inc. Announces Termination of Arrangement Agreement with Midatech Pharma plc
23. Januar 2023 09:22 ET
|
Bioasis Technologies Inc.
NEW HAVEN, Conn., Jan. 23, 2023 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the “Company” or “Bioasis”), a multi-asset rare and orphan disease biopharmaceutical company...
Bioasis Announces Filing of Its Quarterly Financial Statements and MD&A for the Period Ending November 30, 2022
19. Januar 2023 17:05 ET
|
Bioasis Technologies Inc.
NEW HAVEN, Conn., Jan. 19, 2023 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the “Company” or “Bioasis”), a multi-asset rare and orphan disease biopharmaceutical company...
Bioasis Technologies Inc. Mails Management Information Circular for Annual and Special Meeting of Securityholders
11. Januar 2023 17:05 ET
|
Bioasis Technologies Inc.
NEW HAVEN, Conn., Jan. 11, 2023 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the “Company” or “Bioasis”), a multi-asset rare and orphan disease biopharmaceutical company...
Bioasis Technologies Inc. Announces Amendments to Arrangement Agreement with Midatech Pharma plc
19. Dezember 2022 07:47 ET
|
Bioasis Technologies Inc.
NEW HAVEN, Conn., Dec. 19, 2022 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the “Company” or “Bioasis”), a multi-asset rare and orphan disease biopharmaceutical company...
Bioasis Technologies Inc. Announces Shareholder Webinar
14. Dezember 2022 20:00 ET
|
Bioasis Technologies Inc.
NEW HAVEN, Conn., Dec. 14, 2022 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (TSXV:BTI) (OTCQB:BIOAF), (the “Company” or “Bioasis”), a multi-asset rare and orphan disease biopharmaceutical company...
Bioasis Technologies Inc. Announces Merger with Midatech Pharma plc
13. Dezember 2022 12:29 ET
|
Bioasis Technologies Inc.
NEW HAVEN, Conn., Dec. 13, 2022 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the “Company” or “Bioasis”), a multi-asset rare and orphan disease biopharmaceutical company...
Bioasis Announces Filing of Its Quarterly Financial Statements and MD&A for the Period Ending August 31, 2022
28. Oktober 2022 17:18 ET
|
Bioasis Technologies Inc.
NEW HAVEN, Conn., Oct. 28, 2022 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the “Company” or “Bioasis”), a multi-asset rare and orphan disease biopharmaceutical company...